EUVIMEDEUVIMED entdecken
Crossref

Real-Time Single Molecule Imaging Reveals Pathway-Selective Action of Aducanumab on Amyloid-β Aggregation

Takahiro Watanabe-Nakayama iD, Moeko Noguchi-Shinohara, Kenichi Umeda iD, Daiki Muramatsu, Hiroki Konno iD, Noriyuki Kodera iD, Toshio Ando iD, Kenjiro Ono iD

Nano Letters · 2026

DOI: 10.1021/acs.nanolett.6c02842 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nano Letters, 2026. Verfasst von Takahiro Watanabe-Nakayama und 7 weiteren Autor:innen. Beteiligte Einrichtung: WPI Nano Life Science Institute (WPI-NanoLSI), Kanazawa University, Kakuma-machi, Kanazawa920-1192, Japan. Hauptthemen laut MEDLINE: Amyloid beta-Peptides, Antibodies, Monoclonal, Humanized, Single Molecule Imaging, Peptide Fragments. Die Arbeit nennt 50 Literaturangaben. Gefördert von: Kanazawa University, Japan Society for the Promotion of Science, Ministry of Education, Culture, Sports, Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aducanumab is an anti-amyloid-β (Aβ) antibody that binds aggregated Aβ species and has been reported to inhibit secondary nucleation on fibril surfaces. However, how antibody binding influences aggregate dynamics at the molecular level remains incompletely understood. Here, we used high-speed atomic force microscopy (HS-AFM) to directly visualize the interactions between aducanumab and Aβ42 aggregates in real time at single-molecule resolution. Aducanumab extensively decorated oligomers, protofibrils, and fibrils, with fibril binding depending on local surface structure. Consistent with its reported inhibition of secondary nucleation, bulk thioflavin T assays showed slowed aggregation. Nevertheless, in the continued presence of the antibody, protofibril formation proceeded─a pathway distinct from secondary nucleation. These observations reveal a pathway-selective mode of action: extensive surface binding and the suppression of secondary nucleation do not extend to protofibril formation, which proceeds in the continued presence of the antibody.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyloid beta-PeptidesAntibodies, Monoclonal, HumanizedSingle Molecule ImagingPeptide FragmentsAlzheimer DiseaseMicroscopy, Atomic ForceHumansProtein AggregatesProtein Binding

Stichwörter der Autor:innen

AducanumabAlzheimer’s diseaseamyloidhigh-speed atomic force microscopyhumanized monoclonal antibodiessingle molecule imaging

Substanzen

Amyloid beta-PeptidesAntibodies, Monoclonal, HumanizedaducanumabProtein AggregatesPeptide Fragmentsamyloid beta-protein (1-42)

Autor:innen und Institutionen

  • WPI Nano Life Science Institute (WPI-NanoLSI), Kanazawa University, Kakuma-machi, Kanazawa920-1192, Japan.
  • Department of Neurology, Graduate School of Medical Sciences, Kanazawa University, 13-1, Takara-machi, Kanazawa920-8640, Japan.

ORCID-Profile: Takahiro Watanabe-Nakayama, Kenichi Umeda, Hiroki Konno, Noriyuki Kodera, Toshio Ando, Kenjiro Ono

Förderung

  • Kanazawa University
  • Japan Society for the Promotion of Science
  • Ministry of Education, Culture, Sports, Science and Technology

Zitieren

APA

Watanabe-Nakayama, T., Noguchi-Shinohara, M., Umeda, K., Muramatsu, D., Konno, H., Kodera, N., Ando, T., & Ono, K. (2026). Real-Time Single Molecule Imaging Reveals Pathway-Selective Action of Aducanumab on Amyloid-β Aggregation. Nano Letters. https://doi.org/10.1021/acs.nanolett.6c02842

Vancouver

Watanabe-Nakayama T, Noguchi-Shinohara M, Umeda K, Muramatsu D, Konno H, Kodera N, et al. Real-Time Single Molecule Imaging Reveals Pathway-Selective Action of Aducanumab on Amyloid-β Aggregation. Nano Letters. 2026. doi:10.1021/acs.nanolett.6c02842

BibTeX
@article{WatanabeNakayama2026,
  author = {Watanabe-Nakayama, Takahiro and Noguchi-Shinohara, Moeko and Umeda, Kenichi and Muramatsu, Daiki and Konno, Hiroki and Kodera, Noriyuki and Ando, Toshio and Ono, Kenjiro},
  title = {Real-Time Single Molecule Imaging Reveals Pathway-Selective Action of Aducanumab on Amyloid-β Aggregation},
  journal = {Nano Letters},
  year = {2026},
  doi = {10.1021/acs.nanolett.6c02842}
}
Kostenlos starten →